Edward J Ludwig - CVS / CVS Health Corporation - Insider Trade Report

Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Edward J Ludwig in CVS / CVS Health Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2024-05-02	1,000	53.8790	1,000	53.8790	53,879	342	70.1800	16,301	30.25
2023-11-03	2,000	70.4650	2,000	70.4650	140,930
2022-02-10	1,000	105.9044	1,000	105.9044	105,904
2021-08-05	3,000	79.5450	3,000	79.5450	238,635
2021-02-17	3,000	72.0000	3,000	72.0000	216,000
2019-03-08	2,000	52.8000	2,000	52.8000	105,600
2019-03-01	4,000	58.2700	4,000	58.2700	233,080

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Edward J Ludwig in CVS / CVS Health Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Transaction History